News and Publications

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

Anderson Ribeiro 6/12/2019

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
 
For further information, click below to access our full newsletter.

SEARCH

Follow us